Brunel University Research Archive(BURA) preserves and enables easy and open access to all
types of digital content. It showcases Brunel's research outputs.
Research contained within BURA is open access, although some publications may be subject
to publisher imposed embargoes. All awarded PhD theses are also archived on BURA.
Browsing by Author Anikin, V
Showing results 1 to 12 of 12
| Issue Date | Title | Author(s) |
|---|---|---|
| 7-Sep-2021 | Circulating tumour cells and circulating cell-free DNA in lung cancer patients: A comparison between Thoracotomy and Video-Assisted Thoracoscopic Surgery | Katopodis, P; Anikin, V; Kishore, U; Carter, T; Hall, M; Asadi, N; Polychronis, A; Karteris, E |
| 26-Feb-2021 | COVID‑19 and SARS‑CoV‑2 host cell entry mediators: Expression profiling of TMRSS4 in health and disease | Katopodis, P; Kerslake, R; Davies, J; Randeva, HS; Chatha, K; Hall, M; Spandidos, DA; Anikin, V; Polychronis, A; Robertus, JL; Kyrou, I; Karteris, E |
| 17-Jul-2019 | Detection of Abundant Non-Haematopoietic Circulating Cancer-Related Cells in Patients with Advanced Epithelial Ovarian Cancer | Kumar, J; Chudasama, D; Charlotee, R; Kubista, M; Sjoback, R; Chatterjee, J; Anikin, V; Karteris, E; Hall, M |
| 1-Feb-2022 | Differential Expression of RAD51AP1 in Ovarian Cancer: Effects of siRNA In Vitro | Filipe, A; Chudasama, D; Kerslake, R; Jeyaneethi, J; Anikin, V; Kyrou, I; Randeva, H; Sisu, C; Hall, M; Karteris, E |
| 8-Nov-2017 | Identification of novel cancer biomarkers of prognostic value using specific gene regulatory networks (GRN): a novel role of RAD51AP1 for ovarian and lung cancers | Chudasama, D; Bo, V; Hall, M; Anikin, V; Jeyaneethi, J; Gregory, J; Pados, G; Tucker, A; Harvey, A; Pink, R; Karteris, E |
| 24-Nov-2020 | In silico and in vitro analysis of lncRNA XIST reveals a panel of possible lung cancer regulators and a five-gene diagnostic signature | Katopodis, P; Dong, Q; Halai, H; Fratila, CI; Polychronis, A; Anikin, V; Sisu, C; Karteris, E |
| 2016 | Inertia based microfluidic capture and characterisation of circulating tumour cells for the diagnosis of lung cancer | Chudasama, DY; Freydina, MB; Freidin, MB; Leung, M; Fernandez, AM; Rice, A; Nicholson, AG; Karteris, E; Anikin, V; Lim, E |
| 12-Sep-2019 | Kinase inhibitors and ovarian cancer | Katopodis, P; Chudasama, D; Wander, G; Sales, L; Kumar, J; Pandhal, M; Anikin, V; Chatterjee, J; Hall, M; Karteris, E |
| 21-Jan-2020 | Lack of association between screencell-detected circulating tumour cells and long-term survival of patients undergoing surgery for non-small cell lung cancer: A pilot clinical study | Barr, J; Chudasama, D; Rice, A; Karteris, E; Anikin, V |
| 7-Mar-2019 | Liquid biopsies in lung cancer: Four emerging technologies and potential clinical applications | Chudasama, D; Katopodis, P; Stone, N; Haskell, J; Sheridan, H; Gardner, B; Urnovitz, H; Schuetz, E; Beck, J; Hall, M; Barr, J; Sisu, C; Rice, A; Polychronis, A; Anikin, V; Karteris, E |
| 26-May-2020 | Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19 | Katopodis, P; Anikin, V; Randeva, H; Spandidos, D; Chatha, K; Kyrou, I; Karteris, E |
| 9-Jun-2017 | Perioperative detection of circulating tumour cells in patients with lung cancer | Chudasama, D; Burnside, N; Beeson, J; Karteris, E; Rice, A; Anikin, V |